Company Profile
Laboratorio Farmaceutico Erfo S.p.A. is a company specialized in the formulation, production and marketing of nutraceutical products. The business is organized around 4 areas of activity:
- Diètnatural: franchise dedicated to the sale of nutraceutical products linked to weight loss and the ongoing support of professionals specialized in nutrition;
- Division Médicale: a range of nutraceutical products dedicated to specific therapeutic areas (gastroenterology, neurology and musculoskeletal disorders, orthopedics);
- BodySano: French brand dedicated to offering new nutritional coaching methods combined with dietary supplements and aesthetic treatments using innovative tools;
- Fit&Go: Italy's leading franchise network in the world of high-tech fitness and fast fitness, offering customized wellness and health programs.
- Diètnatural: franchise dedicated to the sale of nutraceutical products linked to weight loss and the ongoing support of professionals specialized in nutrition;
- Division Médicale: a range of nutraceutical products dedicated to specific therapeutic areas (gastroenterology, neurology and musculoskeletal disorders, orthopedics);
- BodySano: French brand dedicated to offering new nutritional coaching methods combined with dietary supplements and aesthetic treatments using innovative tools;
- Fit&Go: Italy's leading franchise network in the world of high-tech fitness and fast fitness, offering customized wellness and health programs.
Source: Cofisem - Last Update: 2025-08-11
Key Executives
| Chairman and Chief Executive Officer | |
| Head of Investor Relations |
Source: Cofisem - Last Update: 2025-08-11
Key Figures
| Millenium | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Net sales | 5,828,485 | 5,737,059 | 4,624,287 | 4,818,434 | 3,904,323 |
| Consumed purchases | 1,675,321 | 1,662,370 | 1,319,870 | 1,370,627 | 1,078,758 |
| Labour costs | 1,260,220 | 1,036,069 | 890,572 | 694,251 | 654,178 |
| Operating profit | 523,867 | 836,742 | 987,032 | 1,580,046 | 1,487,526 |
| Income tax | 173,449 | 224,830 | 232,433 | 389,859 | 350,878 |
| Net income | 352,820 | 590,330 | 716,072 | 1,165,976 | 1,139,930 |
| Net income (Group share) | 366,979 | 553,815 | 716,072 | 1,165,976 | 1,139,930 |
| Fiscal year end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - unit | EUR - unit | EUR - unit | EUR - unit | EUR - unit |
| Account Standards | Local GAAP | Local GAAP | Local GAAP | Local GAAP | Local GAAP |
Source: Cofisem - Last Update: 2025-08-11
Shareholder information
| Active Capital Investment | |
| Free float | |
| Treasury shares |
Source: Laboratorio Farmaceutico Erfo S.p.A. - Last Update: 2025-11-12
Address
Laboratorio Farmaceutico Erfo S.p.A.
Viale Geki Russo 9
IT-98049 Villafranca Tirrena
Italy
Phone number: +39 090 914 6125
https://www.erfo.it/investor-relations-and-governance/
Source: Cofisem - Last Update: 2025-08-11
Contact
Daniele Travisano
Phone number: 090 914 6125
IR@ERFO.IT
Phone number: 090 914 6125
IR@ERFO.IT
Source: Laboratorio Farmaceutico Erfo S.p.A. - Last Update: 2025-11-12
Please contact MyQuestion.Italy@euronext.com for Company Profile support.